Identification of Anti-Helicobacter pylori Compounds From Usnea undulata

被引:2
|
作者
Trung Do [1 ]
Nguyen, Trang T. H. [2 ]
Ha, Thai N. [3 ]
Nhu, Nguyen T. H. [3 ]
Van Lam, Nguyen [3 ]
Tram, Nguyen T. T. [3 ]
Yen Pham [1 ]
机构
[1] VNU Univ Sci, Key Lab Enzyme & Prot Technol, 334 Nguyen Trai, Hanoi, Vietnam
[2] Hanoi Univ Publ Hlth, Lab Ctr, Hanoi, Vietnam
[3] Can Tho Univ Med & Pharm, Can Tho, Vietnam
关键词
Helicobacter pylorix; inhibition; usnic acid; natural compounds; Usnea undulata; IN-VITRO; CONSTITUENTS;
D O I
10.1177/1934578X19864212
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, we evaluated 3 extracts (n-hexane, acetone, and methanol) of Usnea undulata Stirton (Usneaaceae) and 5 isolated compounds [methyl orsellinate (1), methyl beta-orsellinate (2), 7-hydroxyl-5-methoxy-6-methylphtalide (3), usnic acid (UA) (4), and salazinic acid (5)] for their inhibitory activity against Helicobacter pylori. The results showed that the n-hexane extract exhibited the strongest activity with the largest inhibition zone (d = 14 mm). For the isolated metabolites, besides UA that has been reported as a potent anti-H. pylori agent, compounds 1 and 2 showed higher inhibition compared to the reference drugs. Our results demonstrated that U. undulata could be a promising source of potential anti-H. pylori metabolites.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Aspects of anti-Helicobacter pylori eradication therapy
    Tytgat, GNJ
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 1996, 1996, : 340 - 347
  • [32] A new look at anti-Helicobacter pylori therapy
    Chuah, Seng-Kee
    Tsay, Feng-Woei
    Hsu, Ping-I
    Wu, Deng-Chyang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (35) : 3971 - 3975
  • [33] Anti-Helicobacter pylori xanthones of Garcinia fusca
    Nontakham, Jannarin
    Charoenram, Napaporn
    Upamai, Wanchalerm
    Taweechotipatr, Malai
    Suksamrarn, Sunit
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (08) : 972 - 977
  • [34] An update on anti-Helicobacter pylori treatment in children
    Khurana, R
    Fischbach, L
    Chiba, N
    van Zanten, SV
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (07): : 441 - 445
  • [35] Anti-Helicobacter pylori antibody IgG and IgA and toxinogenicity of Helicobacter pylori.
    Zhang, QB
    Etolhi, G
    Dawodu, JB
    Nakshabendi, IM
    Mokhashi, MS
    Russell, RI
    Gemmell, CG
    GASTROENTEROLOGY, 1997, 112 (04) : A1127 - A1127
  • [36] A new look at anti-Helicobacter pylori therapy
    Seng-Kee Chuah
    Feng-Woei Tsay
    Ping-I Hsu
    Deng-Chyang Wu
    World Journal of Gastroenterology, 2011, 17 (35) : 3971 - 3975
  • [37] Anti-Helicobacter pylori activity of herbal medicines
    Bae, FA
    Han, MJ
    Kim, NJ
    Kim, DH
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (09) : 990 - 992
  • [38] The Controversy over Anti-Helicobacter pylori Therapy
    Bocian, Katarzyna M.
    Jagusztyn-Krynicka, Elzbieta K.
    POLISH JOURNAL OF MICROBIOLOGY, 2012, 61 (04) : 239 - 246
  • [39] Serum anti-Helicobacter pylori antibodies and gastritis
    Yamamoto, I
    Fukuda, Y
    Mizuta, T
    Fukada, M
    Nishigami, T
    Shimoyama, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 21 : S164 - S168
  • [40] Chaenomelin, a New Phenolic Glycoside, and Anti-Helicobacter pylori Phenolic Compounds from the Leaves of Salix chaenomeloides
    Kim, Kyung Ah
    Kang, Dong-Min
    Ko, Yoon-Joo
    Ra, Moon-Jin
    Jung, Sang-Mi
    Yu, Jeong-Nam
    Ahn, Mi-Jeong
    Kim, Ki Hyun
    PLANTS-BASEL, 2024, 13 (05):